FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

30794011000001104: Hydralazine 25mg tablets (AMCo) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Nov 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
95355101000001113 Hydralazine 25mg tablets (AMCo) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111508801000001116 Hydralazine 25mg tablets (Advanz Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydralazine 25mg tablets (AMCo) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) Is a Product containing precisely hydralazine hydrochloride 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) Has active ingredient Hydralazine hydrochloride false Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) Has specific active ingredient Hydralazine hydrochloride true Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Hydralazine 25mg tablets (AMCo) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Hydralazine 25mg tablets (AMCo) 84 tablet Has AMP True Hydralazine 25mg tablets (AMCo) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start